Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Gastrointestinal disorders are related to digestive system and generally affect the colon, small & large intestine and rectum. The disorders include constipation, peptic ulcer diseases and irritable bowel syndrome. The major reason and cause of GI disorders are stress, intake of medicines such as iron pills and anti-depressants and unhealthy eating habits. Symptoms of the gastrointestinal infections include pain, bloating, diarrhea, nausea and vomiting. The major drugs that dominate the gastrointestinal diagnostics and therapeutics market are aciphex, afinitor, akynzeo, dificid and Prilosec.
This report offers an overview of the market trends, drivers, and barriers with respect to the USA Gastrointestinal Therapeutics and Diagnostics market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Gastrointestinal Therapeutics and Diagnostics market. Detailed analysis of key players, along with key growth strategies adopted by Gastrointestinal Therapeutics and Diagnostics industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Salix Pharmaceuticals
Takeda Pharmaceutical Company
Johnson & Johnson
AstraZeneca
Eisai Co, Ltd
Abbott Laboratories
By Type:
Diagnostics
Therapeutics
By End-User:
Gastroenteritis
GI Bleeding
Irritable Bowel Syndrome
Peptic Ulcer Disease (PUD)
Others
By Region:
-
West USA
-
South USA
-
Middle West USA
-
Northeast USA
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Gastrointestinal Therapeutics and Diagnostics Market
-
1.3 Market Segment by Type
-
1.3.1 USA Gastrointestinal Therapeutics and Diagnostics Market Size and Growth Rate of Diagnostics from 2016 to 2027
-
1.3.2 USA Gastrointestinal Therapeutics and Diagnostics Market Size and Growth Rate of Therapeutics from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 USA Gastrointestinal Therapeutics and Diagnostics Market Size and Growth Rate of Gastroenteritis from 2016 to 2027
-
1.4.2 USA Gastrointestinal Therapeutics and Diagnostics Market Size and Growth Rate of GI Bleeding from 2016 to 2027
-
1.4.3 USA Gastrointestinal Therapeutics and Diagnostics Market Size and Growth Rate of Irritable Bowel Syndrome from 2016 to 2027
-
1.4.4 USA Gastrointestinal Therapeutics and Diagnostics Market Size and Growth Rate of Peptic Ulcer Disease (PUD) from 2016 to 2027
-
1.4.5 USA Gastrointestinal Therapeutics and Diagnostics Market Size and Growth Rate of Others from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 West USA Gastrointestinal Therapeutics and Diagnostics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 South USA Gastrointestinal Therapeutics and Diagnostics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 Middle West USA Gastrointestinal Therapeutics and Diagnostics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 Northeast USA Gastrointestinal Therapeutics and Diagnostics Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Gastrointestinal Therapeutics and Diagnostics Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Gastrointestinal Therapeutics and Diagnostics by Major Types
-
3.4.1 Market Size and Growth Rate of Diagnostics
-
3.4.2 Market Size and Growth Rate of Therapeutics
4 Segmentation of Gastrointestinal Therapeutics and Diagnostics Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Gastrointestinal Therapeutics and Diagnostics by Major End-Users
-
4.4.1 Market Size and Growth Rate of Gastrointestinal Therapeutics and Diagnostics in Gastroenteritis
-
4.4.2 Market Size and Growth Rate of Gastrointestinal Therapeutics and Diagnostics in GI Bleeding
-
4.4.3 Market Size and Growth Rate of Gastrointestinal Therapeutics and Diagnostics in Irritable Bowel Syndrome
-
4.4.4 Market Size and Growth Rate of Gastrointestinal Therapeutics and Diagnostics in Peptic Ulcer Disease (PUD)
-
4.4.5 Market Size and Growth Rate of Gastrointestinal Therapeutics and Diagnostics in Others
5 Market Analysis by Regions
-
5.1 USA Gastrointestinal Therapeutics and Diagnostics Production Analysis by Regions
-
5.2 USA Gastrointestinal Therapeutics and Diagnostics Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on USA Economy
6 West USA Gastrointestinal Therapeutics and Diagnostics Landscape Analysis
-
6.1 West USA Gastrointestinal Therapeutics and Diagnostics Landscape Analysis by Major Types
-
6.2 West USA Gastrointestinal Therapeutics and Diagnostics Landscape Analysis by Major End-Users
7 South USA Gastrointestinal Therapeutics and Diagnostics Landscape Analysis
-
7.1 South USA Gastrointestinal Therapeutics and Diagnostics Landscape Analysis by Major Types
-
7.2 South USA Gastrointestinal Therapeutics and Diagnostics Landscape Analysis by Major End-Users
8 Middle West USA Gastrointestinal Therapeutics and Diagnostics Landscape Analysis
-
8.1 Middle West USA Gastrointestinal Therapeutics and Diagnostics Landscape Analysis by Major Types
-
8.2 Middle West USA Gastrointestinal Therapeutics and Diagnostics Landscape Analysis by Major End-Users
9 Northeast USA Gastrointestinal Therapeutics and Diagnostics Landscape Analysis
-
9.1 Northeast USA Gastrointestinal Therapeutics and Diagnostics Landscape Analysis by Major Types
-
9.2 Northeast USA Gastrointestinal Therapeutics and Diagnostics Landscape Analysis by Major End-Users
10 Major Players Profiles
-
10.1 Salix Pharmaceuticals
-
10.1.1 Salix Pharmaceuticals Company Profile and Recent Development
-
10.1.2 Market Performance
-
10.1.3 Product and Service Introduction
-
10.2 Takeda Pharmaceutical Company
-
10.2.1 Takeda Pharmaceutical Company Company Profile and Recent Development
-
10.2.2 Market Performance
-
10.2.3 Product and Service Introduction
-
10.3 Johnson & Johnson
-
10.3.1 Johnson & Johnson Company Profile and Recent Development
-
10.3.2 Market Performance
-
10.3.3 Product and Service Introduction
-
10.4 AstraZeneca
-
10.4.1 AstraZeneca Company Profile and Recent Development
-
10.4.2 Market Performance
-
10.4.3 Product and Service Introduction
-
10.5 Eisai Co, Ltd
-
10.5.1 Eisai Co, Ltd Company Profile and Recent Development
-
10.5.2 Market Performance
-
10.5.3 Product and Service Introduction
-
10.6 Abbott Laboratories
-
10.6.1 Abbott Laboratories Company Profile and Recent Development
-
10.6.2 Market Performance
-
10.6.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure USA Gastrointestinal Therapeutics and Diagnostics Market Size and Growth Rate of Diagnostics from 2016 to 2027
-
Figure USA Gastrointestinal Therapeutics and Diagnostics Market Size and Growth Rate of Therapeutics from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2020
-
Figure Market Share by Type in 2027
-
Figure USA Gastrointestinal Therapeutics and Diagnostics Market Size and Growth Rate of Gastroenteritis from 2016 to 2027
-
Figure USA Gastrointestinal Therapeutics and Diagnostics Market Size and Growth Rate of GI Bleeding from 2016 to 2027
-
Figure USA Gastrointestinal Therapeutics and Diagnostics Market Size and Growth Rate of Irritable Bowel Syndrome from 2016 to 2027
-
Figure USA Gastrointestinal Therapeutics and Diagnostics Market Size and Growth Rate of Peptic Ulcer Disease (PUD) from 2016 to 2027
-
Figure USA Gastrointestinal Therapeutics and Diagnostics Market Size and Growth Rate of Others from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2020
-
Figure Market Share by End-User in 2027
-
Figure West USA Gastrointestinal Therapeutics and Diagnostics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South USA Gastrointestinal Therapeutics and Diagnostics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Middle West USA Gastrointestinal Therapeutics and Diagnostics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast USA Gastrointestinal Therapeutics and Diagnostics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Gastrointestinal Therapeutics and Diagnostics Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2019
-
Figure Market Share of TOP 5 Players in 2019
-
Figure Market Share of TOP 6 Players from 2016 to 2020
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Distribution Map of USA
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Gastrointestinal Therapeutics and Diagnostics
-
Figure Development Trends of Different Types
-
Table Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Gastrointestinal Therapeutics and Diagnostics by Different Types from 2016 to 2027
-
Table Consumption Share of Gastrointestinal Therapeutics and Diagnostics by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Diagnostics
-
Figure Market Size and Growth Rate of Therapeutics
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Gastrointestinal Therapeutics and Diagnostics by Different End-Users from 2016 to 2027
-
Table Consumption Share of Gastrointestinal Therapeutics and Diagnostics by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Gastroenteritis
-
Figure Market Size and Growth Rate of GI Bleeding
-
Figure Market Size and Growth Rate of Irritable Bowel Syndrome
-
Figure Market Size and Growth Rate of Peptic Ulcer Disease (PUD)
-
Figure Market Size and Growth Rate of Others
-
Table USA Gastrointestinal Therapeutics and Diagnostics Production by Regions
-
Table USA Gastrointestinal Therapeutics and Diagnostics Production Share by Regions
-
Figure USA Gastrointestinal Therapeutics and Diagnostics Production Share by Regions in 2016
-
Figure USA Gastrointestinal Therapeutics and Diagnostics Production Share by Regions in 2021
-
Figure USA Gastrointestinal Therapeutics and Diagnostics Production Share by Regions in 2027
-
Table USA Gastrointestinal Therapeutics and Diagnostics Consumption by Regions
-
Table USA Gastrointestinal Therapeutics and Diagnostics Consumption Share by Regions
-
Figure USA Gastrointestinal Therapeutics and Diagnostics Consumption Share by Regions in 2016
-
Figure USA Gastrointestinal Therapeutics and Diagnostics Consumption Share by Regions in 2021
-
Figure USA Gastrointestinal Therapeutics and Diagnostics Consumption Share by Regions in 2027
-
Table West USA Gastrointestinal Therapeutics and Diagnostics Consumption by Types from 2016 to 2027
-
Table West USA Gastrointestinal Therapeutics and Diagnostics Consumption Share by Types from 2016 to 2027
-
Figure West USA Gastrointestinal Therapeutics and Diagnostics Consumption Share by Types in 2016
-
Figure West USA Gastrointestinal Therapeutics and Diagnostics Consumption Share by Types in 2021
-
Figure West USA Gastrointestinal Therapeutics and Diagnostics Consumption Share by Types in 2027
-
Table West USA Gastrointestinal Therapeutics and Diagnostics Consumption by End-Users from 2016 to 2027
-
Table West USA Gastrointestinal Therapeutics and Diagnostics Consumption Share by End-Users from 2016 to 2027
-
Figure West USA Gastrointestinal Therapeutics and Diagnostics Consumption Share by End-Users in 2016
-
Figure West USA Gastrointestinal Therapeutics and Diagnostics Consumption Share by End-Users in 2021
-
Figure West USA Gastrointestinal Therapeutics and Diagnostics Consumption Share by End-Users in 2027
-
Table South USA Gastrointestinal Therapeutics and Diagnostics Consumption by Types from 2016 to 2027
-
Table South USA Gastrointestinal Therapeutics and Diagnostics Consumption Share by Types from 2016 to 2027
-
Figure South USA Gastrointestinal Therapeutics and Diagnostics Consumption Share by Types in 2016
-
Figure South USA Gastrointestinal Therapeutics and Diagnostics Consumption Share by Types in 2021
-
Figure South USA Gastrointestinal Therapeutics and Diagnostics Consumption Share by Types in 2027
-
Table South USA Gastrointestinal Therapeutics and Diagnostics Consumption by End-Users from 2016 to 2027
-
Table South USA Gastrointestinal Therapeutics and Diagnostics Consumption Share by End-Users from 2016 to 2027
-
Figure South USA Gastrointestinal Therapeutics and Diagnostics Consumption Share by End-Users in 2016
-
Figure South USA Gastrointestinal Therapeutics and Diagnostics Consumption Share by End-Users in 2021
-
Figure South USA Gastrointestinal Therapeutics and Diagnostics Consumption Share by End-Users in 2027
-
Table Middle West USA Gastrointestinal Therapeutics and Diagnostics Consumption by Types from 2016 to 2027
-
Table Middle West USA Gastrointestinal Therapeutics and Diagnostics Consumption Share by Types from 2016 to 2027
-
Figure Middle West USA Gastrointestinal Therapeutics and Diagnostics Consumption Share by Types in 2016
-
Figure Middle West USA Gastrointestinal Therapeutics and Diagnostics Consumption Share by Types in 2021
-
Figure Middle West USA Gastrointestinal Therapeutics and Diagnostics Consumption Share by Types in 2027
-
Table Middle West USA Gastrointestinal Therapeutics and Diagnostics Consumption by End-Users from 2016 to 2027
-
Table Middle West USA Gastrointestinal Therapeutics and Diagnostics Consumption Share by End-Users from 2016 to 2027
-
Figure Middle West USA Gastrointestinal Therapeutics and Diagnostics Consumption Share by End-Users in 2016
-
Figure Middle West USA Gastrointestinal Therapeutics and Diagnostics Consumption Share by End-Users in 2021
-
Figure Middle West USA Gastrointestinal Therapeutics and Diagnostics Consumption Share by End-Users in 2027
-
Table Northeast USA Gastrointestinal Therapeutics and Diagnostics Consumption by Types from 2016 to 2027
-
Table Northeast USA Gastrointestinal Therapeutics and Diagnostics Consumption Share by Types from 2016 to 2027
-
Figure Northeast USA Gastrointestinal Therapeutics and Diagnostics Consumption Share by Types in 2016
-
Figure Northeast USA Gastrointestinal Therapeutics and Diagnostics Consumption Share by Types in 2021
-
Figure Northeast USA Gastrointestinal Therapeutics and Diagnostics Consumption Share by Types in 2027
-
Table Northeast USA Gastrointestinal Therapeutics and Diagnostics Consumption by End-Users from 2016 to 2027
-
Table Northeast USA Gastrointestinal Therapeutics and Diagnostics Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast USA Gastrointestinal Therapeutics and Diagnostics Consumption Share by End-Users in 2016
-
Figure Northeast USA Gastrointestinal Therapeutics and Diagnostics Consumption Share by End-Users in 2021
-
Figure Northeast USA Gastrointestinal Therapeutics and Diagnostics Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Salix Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Salix Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of Salix Pharmaceuticals
-
Figure Revenue and Market Share Analysis of Salix Pharmaceuticals
-
Table Product and Service Introduction of Salix Pharmaceuticals
-
Table Company Profile and Development Status of Takeda Pharmaceutical Company
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Takeda Pharmaceutical Company
-
Figure Sales and Growth Rate Analysis of Takeda Pharmaceutical Company
-
Figure Revenue and Market Share Analysis of Takeda Pharmaceutical Company
-
Table Product and Service Introduction of Takeda Pharmaceutical Company
-
Table Company Profile and Development Status of Johnson & Johnson
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson & Johnson
-
Figure Sales and Growth Rate Analysis of Johnson & Johnson
-
Figure Revenue and Market Share Analysis of Johnson & Johnson
-
Table Product and Service Introduction of Johnson & Johnson
-
Table Company Profile and Development Status of AstraZeneca
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca
-
Figure Sales and Growth Rate Analysis of AstraZeneca
-
Figure Revenue and Market Share Analysis of AstraZeneca
-
Table Product and Service Introduction of AstraZeneca
-
Table Company Profile and Development Status of Eisai Co, Ltd
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eisai Co, Ltd
-
Figure Sales and Growth Rate Analysis of Eisai Co, Ltd
-
Figure Revenue and Market Share Analysis of Eisai Co, Ltd
-
Table Product and Service Introduction of Eisai Co, Ltd
-
Table Company Profile and Development Status of Abbott Laboratories
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbott Laboratories
-
Figure Sales and Growth Rate Analysis of Abbott Laboratories
-
Figure Revenue and Market Share Analysis of Abbott Laboratories
-
Table Product and Service Introduction of Abbott Laboratories
-
